H-NLVPMVATV-OH

Ref. 3D-PP41110

Informations sur le produit

• Nom: H-NLVPMVATV-OH

Description

Peptide H-NLVPMVATV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NLVPMVATV-OH include the following: A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex XN Xu, MA Purbhoo, N Chen, J Mongkolsapaya - Immunity, 2001 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(01)00133-9.pdf Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes XH He, LH Xu, Y Liu - World Journal of Gastroenterology: WJG, 2005 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615439/ Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity X Pan, LC Huang, T Dong , Y Peng, V Cerundolo - Journal of , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175913003608 HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a VÎŽ1 variable segment T Ueno , H Tomiyama, M Fujiwara - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324148 Affinity maturation of a T-cell receptor-like antibody specific for a cytomegalovirus pp65-derived peptide presented by HLA-A* 02: 01 SY Lee, DH Ko, MJ Son, JA Kim, K Jung - International Journal of , 2021 - mdpi.comhttps://www.mdpi.com/1422-0067/22/5/2349 Dipeptides catalyze rapid peptide exchange on MHC class I molecules SK Saini , H Schuster - Proceedings of the , 2015 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1418690112 Identificaiton of novel immunogenic human papillomavirus type 16 E7-specific epitopes restricted to HLA-A* 33; 03 for cervical cancer immunotherapy S Kim, HW Chung , HY Kong, JB Lim - Yonsei medical journal, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122651/ Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion Molecules R Noy, M Haus-Cohen, K Oved , T Voloshin - Molecular Cancer , 2015 - AACRhttps://aacrjournals.org/mct/article-abstract/14/6/1327/91951 Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2-restricted T cell epitopes R Hoppes, R Oostvogels , JJ Luimstra - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/10/4803/97379 Genome-wide Screening of Human Papillomavirus-Specific CTL Epitopes Presented by HLA-A Alleles in Cervical Cancer QH Wang, XY Gao, XL Lou, L Yao, ZX Zhang - Journal of Peptide , 2016 - Springerhttps://link.springer.com/article/10.1007/s10989-015-9480-x Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue MJ Maeurer , A Necker, RD Salter - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.1580 Synthesis and ex vivo profiling of chemically modified cytomegalovirus CMVpp65 epitopes MA Jones , JK Notta, M Cobbold - Journal of Peptide , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.930 Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins M Speir , A Authier-Hall, CR Brooks , KJ Farrand - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-14690-5 A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells M Sioud, G Skorstad, A Mobergslien - The FASEB , 2013 - Wiley Online Libraryhttps://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.12-224758 HLA-A2 M Schumacher, T Mutis, B Rodenko, H Ovaa - 2014 - researchgate.nethttps://www.researchgate.net/profile/Robbert-Spaapen/publication/267749463_Altered_Peptide_Ligands_Revisited_Vaccine_Design_through_Chemically_Modified_HLA-A2-Restricted_T_Cell_Epitopes/links/56f1182308aea9fd53a87ca2/Altered-Peptide-Ligands-Revisited-Vaccine-Design-through-Chemically-Modified-HLA-A2-Restricted-T-Cell-Epitopes.pdf Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Delivery of large heterologous polypeptides across the cytoplasmic membrane of antigen-presenting cells by the Bordetella RTX hemolysin moiety lacking the J Holubova, J Kamanova, J Jelinek, J Tomala - Infection and , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/IAI.05711-11 Novel Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell J Bae, R Carrasco , AH Lee , R Prabhala , YT Tai - Blood, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119619166 A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs G Ruan, L Ma, Q Wen , W Luo, M Zhou - Cellular & Molecular , 2008 - nature.comhttps://www.nature.com/articles/cmi200824 Analysis of antigen-specific T-cell responses with synthetic peptides-what kind of peptide for which purpose? F Kiecker, M Streitz, B Ay, G Cherepnev, HD Volk - Human immunology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885904000539 Dendritic Cells Engineered to Express Defined Allo-HLA Peptide Complexes Induce Antigen-specific Cytotoxic T Cells Efficiently Killing Tumour Cells E Stronen, IW Abrahamsen - Scandinavian , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-3083.2008.02223.x Peptide-specific CD8+ T-cell evolution in vivo: Response to peptide vaccination with Melan-A/MART-1 E Jager, H Höhn, A Necker, R Förster - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10165 In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells DE Speiser , D Lienard, MJ Pittet - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200203)32:3%3C731::AID-IMMU731%3E3.0.CO;2-H Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy D Trivedi, RY Williams, RJ O'Reilly, G Koehne - Blood, 2005 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/105/7/2793/20239 Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer D Nobuoka, T Yoshikawa, M Takahashi - Cancer Immunology , 2013 - Springerhttps://link.springer.com/article/10.1007/s00262-012-1366-6 Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients C Sommerer, A Schmitt, A Huckelhoven-Krauss - Vaccines, 2021 - mdpi.comhttps://www.mdpi.com/2076-393X/9/2/133 Random screening of proteins for HLA-A* 0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA C Pelte, G Cherepnev, Y Wang - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/11/6783/80929 Rapid peptide exchange on MHC class I by small molecules elucidates dynamics of bound peptide A Hadeler, A Saikia , M Zacharias , S Springer - Current Research in , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2590255522000130

• Marque: Biosynth